Promotes apoptosis by binding to BCL2, hence preventing the formation of protective BCL2-BAX heterodimers. Directly interacts with BCL2; this interaction prevents the formation of the anti-apoptotic BAX-BCL2 complex. Widely expressed with highest levels in peripheral blood, skeletal muscle and heart, followed by kidney and liver. Induced by TNF through the activation of the NFKB pathway.